J&J Can't Arbitrate Distributor's Claims In Remicade Row
By Christopher Crosby · October 26, 2018, 9:38 PM EDT
A federal judge in Pennsylvania on Friday rejected Johnson & Johnson's bid to force direct purchasers of the immunosuppressant Remicade to arbitrate claims that it compelled insurers not to cover competing biosimilar versions of...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login